Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

Actions
  • Price (GBX)84.30
  • Today's Change0.40 / 0.48%
  • Shares traded1.02m
  • 1 Year change0.00%
  • Beta0.5585
Data delayed at least 15 minutes, as of Nov 22 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Target Healthcare REIT plc had relatively flat revenues (67.75m to 69.55m), though the company grew net income from a loss of 6.57m to a gain of 73.02m.
Gross margin50.75%
Net profit margin104.99%
Operating margin121.67%
Return on assets7.79%
Return on equity10.87%
Return on investment7.98%
More ▼

Cash flow in GBPView more

In 2024, Target Healthcare REIT plc increased its cash reserves by 153.05%, or 23.52m. The company earned 42.35m from its operations for a Cash Flow Margin of 60.88%. In addition the company generated 3.42m cash from investing, though they paid out 22.24m more in financing than they received.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.11
Tangible book value per share1.11
More ▼

Balance sheet in GBPView more

Target Healthcare REIT plc has a Debt to Total Capital ratio of 25.88%, a lower figure than the previous year's 34.67%.
Current ratio1.62
Quick ratio--
Total debt/total equity0.3492
Total debt/total capital0.2588
More ▼

Growth rates in GBP

Year on year, growth in dividends per share fell -8.38% while earnings per share excluding extraordinary items rose 1,210.76%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg)5.50%
Div growth rate (5 year)-2.80%
Payout ratio (TTM)48.52%
EPS growth(5 years)7.76
EPS (TTM) vs
TTM 1 year ago
1,211.80
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.